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Expression of G protein a subunits of the Gq family
with various G protein-coupled receptors induces acti-
vation of an inositol 1,4,5-trisphosphate (IP3)/Ca
21-medi-
ated Cl2 conductance in Xenopus oocytes. Our present
data show that two members of this family, the human
Ga16 subunit and the murine homologue Ga15, can in-
duce both activation and inhibition of these agonist-
induced currents. Although extremely low amounts
(10–50 pg) of injected Ga16 subunit cRNA cause modest
(;2-fold) enhancement of ligand-induced Cl2 currents
in oocytes co-injected with thyrotropin-releasing hor-
mone (TRH) receptor cRNA 48 h postinjection, larger
Ga16 and Ga15 cRNA injections cause>10-fold inhibition
of TRH or 5HT2c receptor responses. The inhibition is
analyzed in this study. The inhibited currents are recov-
ered if various Gbg subunit combinations are also ex-
pressed with the Ga subunits. The constitutively active
mutant, Ga16Q212L, also causes a strong attenuation of
the ligand-induced Cl2 currents, but this inhibition is
not recovered by co-expression of Gbg subunits. These
results indicate that the free Ga subunit is responsible
for the inhibitory signal. Although expression of TRH
receptor alone produces maximum responses approxi-
mately 48 h after injection, co-expression of TRH recep-
tor with Ga16 results in enhanced responses 6–12 h
postinjection, followed by complete attenuation at 36 h.
Furthermore, injection of Ga16 cRNA alone at compara-
ble levels gives rise to spontaneous Cl2 currents within
6–12 h postinjection, suggesting that the early sponta-
neous activation underlies the later suppression. Ex-
pression of other G protein a subunits of the Gq family,
at cRNA levels considerably higher than effective for
Ga16, produces both analogous spontaneous Cl
2 cur-
rents and, later, inhibition of ligand-induced Cl2 cur-
rents. Experiments with direct injection of IP3 and of
Ca21 suggest that this inhibition is consistent with the
down-regulation of IP3 receptors. These data indicate
that both enhancement and inhibition of signaling
through G protein-coupled receptors can be mediated
by the expression level and/or activity of an individual G
protein.
Many hormones, neurotransmitters, and growth factors act
via G protein-coupled receptors (GPCRs)1 in a wide range of
transduction processes. The phosphoinositide cascade, which
controls calcium-stimulated processes such as secretion, che-
motaxis, and fertilization, is regulated by G proteins. Phospho-
inositide phospholipase C (PLC) catalyzes the hydrolysis of
phosphatidyl 4,5-bisphosphate to generate two second messen-
gers, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. Dia-
cylglycerol in turn activates protein kinase C; IP3 binds to an
intracellular IP3 receptor/channel to release Ca
21 stores (Ref. 1
and references therein). In mammals, several families of PLC
isoforms have been described (2, 3). The PLC b isoform is
regulated by G proteins. All four b isoforms of PLC are acti-
vated via the pertussis toxin-insensitive Gaq family of G pro-
teins: Gaq, Ga11, Ga14, Ga15, and Ga16, although isoforms
appear to vary with respect to potency for activation (4–6). Two
isoforms, PLC b2 and PLC b3, can also be activated by Gbg
(6–9). It also has been shown that the Ga and Gbg subunits
bind to different regions of the PLC b enzyme (10, 11).
The complexity of the molecular components and the func-
tional interaction among them enable many variations in the
control and timing of particular signaling pathways. Such spec-
ificity of signaling may be important in determining the cell’s
response to an extracellular signal. The pattern of expression of
receptors, G proteins, and effectors may also play an important
role in this selectivity process. For instance, the Ga16 and Ga15
subunits show a restricted pattern of expression (12, 13); con-
versely, they have a promiscuous behavior with respect to
receptor coupling (14, 15). Regulatory processes such as short
and long term desensitization may also determine the effi-
ciency of signal transduction in a cell.
In Xenopus oocytes, activation of PLC by ligand-activated
GPCRs produces the opening of a Cl2 channel via Ca21 release
from intracellular stores; this system has been extensively used
for the study of GPCRs. Many receptors couple to an endoge-
nous pertussis toxin-sensitive G protein when expressed in
oocytes (16–18); this pathway seems to involve Go. It is still
unclear whether the bg-dependent activation of PLC b ac-
counts for the pertussis toxin-sensitive regulation of PLC. Re-
cent data suggest that the Gbg dimer regulates the activity of
PLC in oocytes (19). Other receptors, e.g. the thyrotropin-re-
leasing hormone (TRH) receptor, activate PLC via pertussis
toxin-insensitive G proteins in oocytes (20, 21). Antisense ex-
periments show that these G proteins are members of the Gq
family. Additionally, the expression level of G proteins influ-
ences the selectivity of receptor/G protein coupling (21). Prom-
iscuity of receptor/G protein interactions appears with increas-
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ing levels of G protein expression, indicating that the level of
expression of G proteins and receptors are important for mod-
ulating transmembrane signaling.
Regulation of the PLC cascade in oocytes is an important
step in oocyte maturation and fertilization. For example, it has
been shown that G proteins of the Gq family increase in expres-
sion level as the oocyte matures and acquires the capacity to
respond to IP3 (22). Although the IP3 receptors are localized
mostly in the cytoplasm of the oocyte, they are found mostly in
the cortical region of the mature egg (23). In the egg, an in-
crease in Ca21 concentration occurs at fertilization and propa-
gates Ca21 waves that are required for the prevention of
polyspermy and for the induction of cell cycle changes (24). In
this study, we present further evidence for regulation of the
pathway leading from the activation of G proteins to the acti-
vation of Cl2 channels. We use this signaling cascade to exam-
ine the role of G proteins of the Gq family to GPCR stimulation.
We show that overstimulation of PLC, by means of expression
of Ga subunits of the Gq family, produces signal inhibition and
that this effect is the result of a decreased physiological re-
sponse to IP3 activation. We suggest that this effect is part of a
desensitization process controlling the stimulation of the PLC
pathway and that both enhancement and inhibition of signal-
ing through GPCRs can be mediated by the level of G protein
expression and/or activity.
EXPERIMENTAL PROCEDURES
In Vitro Synthesis of RNA—In vitro transcription of sense RNA was
carried out as described previously (25) with a few modifications. Re-
combinant plasmids containing cDNA inserts were linearized by diges-
tion with appropriate restriction enzymes. The transcription of linear-
ized templates was performed in 7.6 mM Tris-HCl, pH 7.6, 6 mM MgCl2,
0.6 mM NaCl, and 10 mM dithiothreitol containing 0.5 mM each ATP,
CTP, and UTP, 0.1 mM GTP, 0.5 mM 59-(7-methyl)-GTP, and 180 units
of the respective polymerase in a total volume of 250 ml. The reaction
mixture was incubated for 150 min at 37 °C. The DNA template was
subsequently removed by treatment with 5 units of RNase-free DNase
I for 15 min at 37 °C. Free nucleotides were removed using a Sephadex
G50 column. The mRNA was phenol-chloroform-extracted and recov-
ered by ethanol precipitation. The RNA was dissolved in RNase-free
water at the corresponding concentration (see figure legends), divided
into aliquots, and stored at 270 °C until used.
Oocyte Expression and Electrophysiology—These procedures are de-
scribed in detail elsewhere (26). Briefly, oocytes were defolliculated and
maintained at 18 °C in incubation medium containing ND96 (96 mM
NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.4), 1.8 mM CaCl2, 50
mg/ml gentamycin, and 5% horse serum (27). Whole cell currents were
measured at room temperature using either a Dagan 8500 amplifier or
an Axon Instruments GeneClamp in a standard two-microelectrode
voltage clamp configuration. Current was measured on-line by oscillo-
scope and chart recorder. Electrodes were filled with 3 M KCl and had
a resistance of 1–2 megaohms. During experiments, the oocytes were
clamped at 280 mV and superfused continuously in ND96 medium; all
drugs were applied in this solution. Injections of IP3 and Ca
21 were
performed using a pressure injector and a small bore (;2-mm) injection
pipette.
Materials—TRH was from Peninsula Laboratories (Belmont, CA),
and 5HT was from Research Biochemicals Inc. (Natick, MA). All other
drugs and reagents were from Sigma.
RESULTS
Enhancement and Inhibition of Responses by G Protein Sub-
units—Superfusion of TRH onto oocytes voltage-clamped at
negative holding potentials (280 mV) and expressing TRH
receptor produced an inward current characteristic of the PLC-
and IP3-mediated Ca
21-activated Cl2 conductance (Fig. 1A).
We have shown previously (21) that the response increases
monotonically with the receptor cRNA concentration under the
conditions of these experiments. In addition, co-injection of
cRNA for some G protein a subunits (Gaq, Ga11, Ga14, Gaoa,
and Gaob in the range of 1–5 ng of cRNA) as well as for receptor
enhances agonist-induced currents (maximum 4–6-fold in-
crease) over the values for receptor injections alone (21).
Surprisingly, when cRNA for another member of the Gq
family, Ga16, was co-injected with the TRH receptor cRNA, a
FIG. 1. Agonist-induced Cl2 currents in oocytes are inhibited
by co-expression of Ga16. A, recordings from individual oocytes in-
jected 48 h earlier with 0.2 ng of TRH receptor cRNA alone or in
combination with 1 ng of Ga16 cRNA. The solid bars above each trace
represent the application of 10 nM TRH for 20 s, used for all data on
TRH responses. B, biphasic relationship between the amount of injected
Ga16 cRNA and the magnitude of inward Cl
2 current elicited. The TRH
responses are enhanced for Ga16 cRNA #0.05 ng and inhibited at
higher concentrations. Amounts of injected cRNA (ng) for each condi-
tion are shown below the abscissa. Comparable inhibitions were found
substituting Ga15 cRNA and/or 5HT2c receptor cRNA (inset). For the
5HT2c injected oocytes, currents were elicited with a 20-s application of
1 nM 5HT. Data are the mean 6 S.E. for 7–12 oocytes/condition recorded
48 h postinjection. C, increased TRH-induced Cl2 currents due to Gaq
are inhibited by Ga16 co-expression. Amounts of injected cRNA (ng) for
each condition are shown below the abscissa. Data are the mean 6 S.E.
for 5–8 oocytes/condition recorded 48 h postinjection.
Ga16 Inhibition of Ligand-induced Cl
2 Currents32022
strong inhibition of the TRH-induced peak inward current was
observed 48 h postinjection (Fig. 1A). The inhibition depended
on the amount of cRNA injected (Fig. 1B), reaching .90% at 1
ng of Ga16 cRNA, and occurred at cRNA amounts 10 times
lower than the injection amounts at which other G protein a
subunits produced detectable increases in ligand-induced Cl2
currents (e.g. see Fig. 1C). This suggested that Ga16 was more
potent than other members of the Gaq subfamily. High potency
is also suggested by the fact that even smaller quantities of
Ga16 cRNA (0.001–0.05 ng) actually increased TRH-induced
currents (Fig. 1B). However, this paper focuses on the novel
inhibition produced by Ga16 cRNA levels at injected levels $0.5
ng. Each of several cRNA preparations yielded such inhibition.
As was seen with oocytes expressing Ga16 and TRH receptor,
Ga16 also inhibited peak inward currents in oocytes injected
with the serotonin 5HT2c receptor and perfused with 5HT (Fig.
1B, inset). Ga16 is the human homologue of murine Ga15, an-
other member of the Gq family of G protein a subunits. The
murine homologue Ga15 inhibited TRH or 5HT responses sim-
ilarly to Ga16 (Fig. 1B, inset).
We have examined other aspects of the inhibition of the
signaling pathway by these two G protein a subunits. We
studied first the effect of co-injecting Gaq cRNA (which leads to
enhancement of TRH-induced Cl2 currents) with Ga16 cRNA.
In oocytes injected with 8 times less Ga16 cRNA than Gaq (at
Gaq levels that by themselves increased the TRH-induced Cl
2
current 2–3-fold), the .5-fold inhibition of Cl2 currents by
Ga16 was the dominant effect (Fig. 1C).
Ga16 and Ga15 are expressed in hematopoietic lineages of
human and mouse, respectively (12, 13). They activate the PLC
b2 expressed in these lineages and also other PLC b isoforms
(10, 28, 29). We considered the possibility that the inhibition
observed in oocytes could be due to the inability of Ga16 or Ga15
to activate the corresponding PLC b isoform, termed PLC Xb,
present in Xenopus oocytes. However, the enhancement ob-
served at low injected Ga16 concentrations argues against this
possibility. Also, we have recently shown that Ga16 and Ga15
can activate PLC Xb2 by co-expressing Xenopus phospholipase
PLC Xb with various Ga subunits in transiently transfected
COS-7 cells. Therefore, it seems unlikely that the inhibitory
effect we observed when expressing Ga15 or Ga16 in oocytes
was due to the inability of these subunits to activate down-
stream effectors.
These results prompted us to seek other evidence for the
hypothesis that Ga16 or Ga15 subunits in oocytes activate the
PLC Xb and that the prolonged activation by free Ga subunits
induces Cl2 current inhibition. We co-injected Gbg subunits
with Ga16 in presence of the TRH receptor (Fig. 2). Functional
activity of the Gbg dimer was verified by co-expressing these
subunits with the inward rectifying atrial potassium channel
(GIRK1), which is activated by free Gbg subunits (31–33).
Co-injection of Gbg with TRH receptor and Ga16 prevented
most of the inhibition produced by co-injection of TRH receptor
and Ga16 alone. Subunit combinations consisting of Gb1g2 and
Gb2g2 were each capable of recovering these currents. We
believe that this effect occurs because Gbg sequesters free Ga
and therefore prevents the action of free Ga subunits on down-
stream effectors. We also considered the possibility that Gbg
alone had an effect on the activity of PLC Xb independent of the
Ga subunit, but we observed no significant change in ligand-
induced Cl2 currents when TRH receptor was co-injected with
G (in the absence of injected Ga subunit cRNA) (Fig. 2). This
result argued against a direct effect of Gbg on ligand-induced
PLC activation under our conditions. We further addressed
this question by injecting the constitutively active mutant of
Ga16, Ga16Q212L, which does not bind to Gbg. The Ga16Q212L
mutation produced the same inhibitory effect on TRH-induced
Cl2 currents as did wild-type Ga16, but this effect could not be
reversed by the presence of Gbg (Fig. 3).
The data presented thus far are consistent with the hypoth-
esis that free Ga16 subunits produce the inhibitory effect. More
specifically, Ga16 would inhibit via the sequelae of overstimu-
lation of the PLC b pathway.
Spontaneous Responses with G Protein Subunits—Further
2 Ma, H., Magnusson, R. P., Iyengar, R., and Aragay, M., submitted
for publication.
FIG. 2. Inhibition of agonist-induced Cl2 currents by Ga16 is
eliminated by co-expression of various G protein b and g sub-
units. Amounts of injected cRNA (ng) for each condition are shown
below the abscissa. Functional Gb and Gg subunit expression was
confirmed by co-expression with 1 ng of GIRK1 cRNA and measurement
of currents in the presence of saline containing high K1 (96 mM KCl, 1
mM NaCl; see Ref. 30). Data are the mean 6 S.E. for 6–8 oocytes/
condition recorded 48 h postinjection.
FIG. 3. Expression of constitutively active Ga16 inhibits ago-
nist-induced Cl2 currents that are not recovered by co-expres-
sion of Gb and Gg subunits. Amounts of injected cRNA (ng) for each
condition are shown below the abscissa. Data are the mean 6 S.E. for
6–8 oocytes/condition recorded 48 h postinjection.
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evidence for an activity of free Ga was obtained from examining
the effect of expressing Ga16 alone or with TRH receptor at
various times following cRNA injection. The results of these
time course experiments are shown in Fig. 4A. Injection of
cRNA for TRH receptor produces a monotonic increase in Cl2
currents from 6 to 50 h postinjection. This response is most
likely due to increasing amounts of receptor with time after
injection. At 6 h postinjection, co-injection of TRH receptor and
Ga16 cRNA produced a ligand-induced peak inward current 4
times larger than in oocytes expressing TRH receptor alone.
Contrary to the responses of oocytes expressing TRH receptor
alone, oocytes with both TRH receptor and Ga16 showed a
FIG. 4. Time course of inhibition
and presence of spontaneous cur-
rents for coexpression of Ga16 alone.
A, oocytes were injected with cRNA en-
coding the TRH receptor (filled circles),
Ga16 (open circles), or both (open trian-
gles). Measurement of Cl2 currents for
each group of oocytes was performed at
various times following cRNA injection
(abscissa). For the two oocyte groups ex-
pressing TRH receptor, currents were
elicited with at a holding potential of 280
mV. The holding current prior to TRH
application was less than 2200 nA in all
oocytes. For the oocytes injected with
Ga16 cRNA alone, the oocyte was clamped
at the Cl2 equilibrium potential (approx-
imately 225 mV) and then jumped to 280
mV for 5 s. Data are the mean 6 S.E. for
5–7 oocytes/condition/time point; some oo-
cytes in each group were measured at
more than one time point. B, recordings
from individual oocytes injected with 10
ng of Ga16 cRNA at various time points
postinjection. The solid bars above each
trace represent a voltage jump from the
Cl2 equilibrium potential to 280 mV. For
comparison, the response of a represent-
ative uninjected oocyte is included. C,
increasing the concentration of injected
Gaq cRNA inhibits agonist-induced Cl2
currents. Amounts of injected cRNA (ng)
for each condition are shown below the
abscissa. Data are the mean 6 S.E. for
4–6 oocytes/condition recorded 48 h
postinjection.
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decrease in peak inward currents after 12 h and complete
attenuation after 36 h.
In oocytes injected with Ga16 alone, we also observed an
important new phenomenon: spontaneous oscillatory Cl2 cur-
rents. These spontaneous responses with Ga16 also provide
further evidence that the Ga16 subunit alone can activate PLC
Xb. In general, injection of larger cRNA amounts resulted in
larger peak spontaneous currents, larger numbers of sponta-
neous events, and a longer response duration at earlier time
points as compared with oocytes injected with smaller amounts
of cRNA. For 10-ng injections, the spontaneous signals were
maximal (;600 nA) at 12 h and decreased afterwards (Fig. 4, A
and B). For 0.5-ng injections, the spontaneous currents also
peaked in amplitude at 12 h and vanished by 48 h but had
considerably smaller amplitudes (Table I). For 0.05-ng injec-
tions, the spontaneous currents occurred only after $24 h,
persisted until at least 48 h, and were only a few nA in ampli-
tude (Table I). Fig. 4A shows that the peak and subsequent
decline in the spontaneous responses for oocytes expressing
Ga16 alone has a time course that matches the peak and decline
of TRH responses for oocytes expressing both TRH receptor and
Ga16, as if the spontaneous responses are first activated and
later inhibited by the same mechanism that first enhances and
later inhibits the receptor responses. In the most straightfor-
ward hypothesis, inhibition of the signaling pathway is the
eventual result of spontaneous activation induced by Ga16.
Because we hypothesize that Ga16 differs from other G pro-
teins, for instance Gaq, primarily in the quantitative potency of
coupling, we have sought and found spontaneous oscillations
induced by the latter G protein as well (Table I). These re-
sponses occur at injection levels (5 and 25 ng) greater than
those previously studied (21).
Inhibition at High Gaq Levels—The hypothesis that Ga16
differs only quantitatively from other G proteins, because of
intrinsic activity, also led us to seek an inhibitory effect of other
G proteins. An inhibitory effect analogous to that produced by
Ga16 could indeed be observed with other G protein a subunits
that activate PLC, again when injected at higher cRNA con-
centrations than previously tested (21). In Fig. 4C we present
the results for co-injection of increasing quantities of Gaq cRNA
with TRH receptor cRNA. Similar results were observed with
Ga11 co-expression and with other receptors (data not shown).
Localization of the Inhibitory Effect at IP3 Receptors—We
next sought to determine where along the pathway the inhib-
itory signal was produced. Mammalian PLC is the target of
phosphorylation by various kinases (34, 35). Some of these
modifications inactivate the enzyme. The IP3 receptor can also
be phosphorylated by various kinases, although the effects on
the activity are not clear (see Ref. 36). We tested the hypothesis
that activation of PLC, which leads to generation of diacylglyc-
erol and the concomitant activation of protein kinase C, would
in turn lead to the inactivation of a key messenger of this
signaling cascade. Oocytes injected with 1 ng of Ga16 were
treated either chronically (from 1 h postinjection to the time of
assay) or acutely (1 h prior to assay) with protein kinase C
inhibitors (either staurosporine or bisindolylmaleimide). Little
change in spontaneous Cl2 currents induced by Ga16 expres-
sion was observed with any of the conditions tested (data not
shown). We also co-injected excess PLC Xb cRNA to determine
whether it is the rate-limiting step in Ga16 inhibition. Co-
injection of PLC Xb produced a 2-fold increase in the ligand-
induced Cl2 currents but did not prevent the inhibition pro-
duced by the presence of Ga16 (data not shown).
IP3 binds to a specific receptor on intracellular membranes
and is a key control point in the regulation of phospholipase-
activating pathways. To study the role of the IP3 receptor in
Ga16 inhibition, we injected IP3 directly into the oocyte, bypass-
ing G protein induction of PLC. These experiments were per-
formed with oocytes expressing either Ga16 alone or Ga16 plus
TRH receptor. A rapid induction of Cl2 currents was observed
upon injection of 100 pmol of IP3 in all oocytes. Fig. 5A sum-
marizes the data and shows representative traces. However,
oocytes injected with Ga16 with or without receptor showed a
marked reduction in IP3-induced Cl
2 currents (to ;30% of
control).
We next studied the effect of activating the Cl2 channel
directly by injecting Ca21 into the oocyte. Injection of 50 pmol
of CaCl2 produced comparable responses in control oocytes and
in oocytes injected with Ga16 (Fig. 5B). These results indicate
that the Cl2 channels themselves were not affected by the
prolonged stimulation of the PLC b pathway and suggest that
the reduction of the peak currents observed in oocytes express-
ing Ga16, Ga15, or other Ga subunits in excess is a consequence
of physiological alterations in IP3 receptor responses.
DISCUSSION
Activation of GPCRs expressed in Xenopus oocytes generates
a well characterized second messenger cascade that leads to
opening of Ca21-activated Cl2 channels. However, regulation
of the sensitivity in this cascade is only partially understood. In
the present study, we show that the expression of the human
Ga16, or the murine homologue Ga15, produces inhibition of
peak inward Cl2 currents activated via GPCRs when measured
more than 24 h postinjection. This inhibitory effect is likely the
result of a desensitization process that blocks the release of
Ca21 from internal stores, due to the prolonged activation of
PLC b by free Ga16 subunits. As evidence for such a mecha-
nism, we show that (i) expression of Ga16 or Ga15 inhibits the
currents induced by ligands for each of two co-expressed recep-
tors; (ii) co-expression of Gbg with Ga16 subunits restores this
current; (iii) the presence of the activated mutant of Ga16,
Ga16Q212L, results in a similar block of the ligand-induced Cl
2
conductance, but co-injection of Gbg does not restore the signal;
(iv) oocytes injected with Ga16 alone display a spontaneous Cl
2
conductance at 6–12 h postinjection, after which peak currents
decrease; and (v) in oocytes injected with Ga16 and TRH recep-
tor cRNA, agonist produces larger than normal currents at
TABLE I
Comparison of spontaneous oscillations in oocytes following injection
of Ga16 or Gaq cRNA
Oocytes were injected with either Ga16 (0.05 or 0.5 ng; see Fig. 1B) or
Gaq (5 or 25 ng; see Fig. 4C). Spontaneous currents were measured
(holding potential, 280 mV) in recordings lasting for 5 min at 12, 24, 36,
and 48 h postinjection.
Subunit RNAamount
Time
postinjection
Spontaneous
eventsa
Peak
spontaneous
current
Cell 1 Cell 2 Cell 1 Cell 2
ng h nA nA
Ga16 0.05 12 0 0 0 0
24 0 1:2 0 ;2
36 2:13 4:10 ;3 ;5
48 2:7 2:6 ;2 ;3
0.5 12 6:18 14:15 72 63
24 13:10 3:9 ;8 49
36 0 7:11 0 ;2
48 0 0 0 0
Gaq 5.0 12 0 0 0 0
24 0 0 0 0
36 0 2:6 0 ;3
48 1:8 0 ;6 0
25.0 12 1:12 8:14 40 22
24 5:6 8:12 27 31
36 1:15 0 ;8 0
48 1:8 0 ;5 0
a Spontaneous events are shown as the ratio of the number of events
to duration (in seconds).
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early times postinjection (6–12 h) but a reduced response at
later times. These effects suggest that the signaling cascade
initiated through a single GPCR can be both enhanced and
inhibited depending upon the level of G protein expression
and/or activity.
The prolonged activation of PLC b by free Ga15 or Ga16 that
results in signal inhibition is likely not a peculiarity of Ga16 or
Ga15 subunits. Low quantities of other Ga subunit cRNAs
enhance transmitter responses (21), but when higher quanti-
ties of other Ga subunit cRNAs are injected there is an inhib-
itory effect analogous to that seen with smaller quantities of
Ga16, in agreement with previous observations injecting large
amounts of wild-type Gaq (37). We suggest that any prolonged
stimulation of the PLC pathway in oocytes will result in signal
down-regulation.
It is at first surprising that the rather small spontaneous
currents with 0.5 ng of Ga16 cRNA (60–70-nA peak, at 12 h
after injection) represent activation sufficient to desensitize
most of the release mechanism. We point out, however, that the
spontaneous activation is present for many hours, whereas
most experiments on oocytes utilize a single application of
agonist, lasting just seconds. Furthermore, the IP3 receptors
that mediate the spontaneous currents have presumably been
desensitized by the same process that desensitizes the re-
sponses to exogenously applied agonists. We do not know
whether Ca21 itself is the desensitizing factor, but previous
studies show that neither activation nor desensitization of the
Cl2 channel response is simply related to the concentration of
intracellular Ca21 (38, 39). The barely detectable spontaneous
responses to 0.05 ng of Ga16 (Table I) were evidently not asso-
ciated with activation sufficient to desensitize the signaling
pathway (Fig. 1B).
One important question concerns the mechanism by which
the wild-type Ga16 or Ga15 subunit produces this dramatic
effect even at relatively low quantities of cRNA injected, while
other subunits need to be constitutively active or injected at
higher quantities. These two subunits have the peculiarity that
they couple to a broad range of GPCRs (14). One possibility
could be that these G proteins in the oocyte are being activated
by endogenous receptors. On the other hand, a lower affinity
for endogenous Gbg subunits or a higher efficiency in activat-
ing endogenous PLC b isoforms may account for the unusual
effects of Ga16 or Ga15 on the Cl
2 current response. It is
interesting to note that injection of 1–5 ng of the other Ga
subunit cRNAs produces an increase in peak current when
co-injected with TRH receptor (21). Above this amount, all Ga
subunits of the Gq family induce desensitization. Presumably,
above a threshold at which excess Ga subunits can no longer
interact with Gbg and couple to the receptor, the free Ga
subunits induce activation of PLC and induce signal desensi-
tization. Because we have no direct measurements of Ga sub-
unit levels, it remains possible that the unusual effects of Ga16
or Ga15 occur simply because unusually large amounts of these
Ga subunits are produced in the oocyte.
This study shows that Ga16 and Ga15 subunits join the list of
pertussis toxin-insensitive G protein subunits that can activate
an effector in oocytes, leading to Ca21 mobilization (21). cDNAs
Ca21 eliminates the Ga16-mediated inhibition of Cl
2 currents. Voltage-
clamp currents were measured at a holding potential of 280 mV during
injection of 25 nl of H2O containing 100 pmol of IP3. Amounts of injected
cRNA (ng) for each condition are shown below the abscissa. Data are the
mean 6 S.E. for 4 oocytes/condition recorded 48 h postinjection. Rep-
resentative traces below each graph are for oocytes expressing TRH
receptor alone or in combination with Ga16. The initial inward deflec-
tion prior to IP3 or Ca
21 injection is a mechanical artifact due to
insertion of the injection pipette.
FIG. 5. Cl2 currents induced by IP3 injection are smaller in
oocytes expressing Ga16, but currents induced by Ca
21 injection
are normal. A, voltage clamp currents were measured at a holding
potential of 280 mV during injection of 25 nl of H2O containing 100
pmol of IP3. Amounts of injected cRNA (ng) for each condition are shown
below the abscissa. For comparison, currents elicited with a 20-s appli-
cation of 10 nM TRH are shown in the inset. Data are the mean 6 S.E.
for 6–8 oocytes/condition recorded 48 h postinjection. B, injection of
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for other pertussis toxin-insensitive G proteins, including Gaq
and Ga11, have been cloned from Xenopus (37, 40). Using an-
tibodies against the C-terminal sequence of mouse Gq it has
been shown that oocytes express several forms of the Gq family
of a subunits (22). There has, however, been some controversy
concerning the ability of G proteins of the Gaq family to acti-
vate the PLC cascade in the oocytes. Our earlier study showed
that responses are enhanced by injection of cRNA for Gaq or
Ga11 (21), but in other reports Gaq or Ga11 injected into the
oocyte has reduced Cl2 currents (19, 41). The results presented
here support the idea that the Ga subunit of all members of the
Gaq family can couple to GPCRs and activate the oocyte’s
IP3/Ca
21-induced Cl2 conductance. Under certain conditions,
this coupling can eventually produce an inhibitory signal that
we suggest may be due to the overexpression of G protein a
subunits and, therefore, to overstimulation of phospholipase
Cb.
IP3 is a key second messenger for the mobilization of Ca
21
from internal stores. An IP3 receptor isoform has been cloned
from oocytes (23). Previous experiments had shown that injec-
tion of IP3 into oocytes renders them unresponsive to subse-
quent stimulation by either receptor activation or IP3 injection
(42). Recently, Honda et al. (43) showed that the loss of IP3
sensitivity due to down-regulation of the IP3 receptor is the
main reason for the Gaq-induced desensitization of the platelet-
activating factor receptor response. The results presented here
demonstrate that the presence of wild type Ga16 and Ga15 is
enough to produce a similar desensitization effect and extend
the observation to the other members of the Gq family. Taken
together, these results suggest that the regulation of the IP3
receptor plays a pivotal role in the propagation of agonist-
mediated Ca21 transients. This study provides a model to
study the mechanism of a more physiological effect like heter-
ologous desensitization, where the activation of several recep-
tors may trigger similar down-regulation responses. The pre-
cise mechanism of down-regulation of the IP3 receptor remains
unclear.
In mammals three different isoforms of IP3 receptors have
been identified. There is accumulating evidence that individual
isoforms have distinct tissue and subcellular localization, phar-
macological properties, and regulation by calcium and phos-
phorylation (see Ref. 36). For example, the type I IP3 receptor
is down-regulated in carbachol-stimulated human neuroblas-
toma cells (44, 45). It will be interesting to ascertain how
persistent activation of PLC by different G protein a subunits
or bg subunits affects the regulation of agonist-mediated Ca21
transients in other cellular environments.
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